Medical
Nyxoah’s Genio Sleep Implant Cuts Sleep Apnea Events by 74% in 12-Month US Trial
Nyxoah's Genio implant cut sleep apnea breathing events by a median 74.3% at 12 months in the US…
Nyxoah's Genio implant cut sleep apnea breathing events by a median 74.3% at 12 months in the US…
The FDA granted two Breakthrough Therapy Designations to AbbVie's telisotuzumab adizutecan for colorectal and lung cancers on October…